ASGCT 2025 - In vivo generated CAR-T using T cell-targeting Lentivirus vectors shows high tumor control efficacy in a PBMC-humanized model Published Date October 14, 2025 Expand Fullscreen Exit Fullscreen Download PDF Expand Fullscreen